Does NATALIZUMAB Cause Cerebral atrophy? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Cerebral atrophy have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.1% of all adverse event reports for NATALIZUMAB.
29
Reports of Cerebral atrophy with NATALIZUMAB
0.1%
of all NATALIZUMAB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Cerebral atrophy From NATALIZUMAB?
Of the 29 reports, 1 (3.4%) resulted in death, 7 (24.1%) required hospitalization.
Is Cerebral atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Cerebral atrophy?
FINGOLIMOD (87)
VALPROIC ACID (84)
PHENYTOIN (58)
METHOTREXATE (55)
LEVETIRACETAM (54)
CYCLOPHOSPHAMIDE (52)
OLANZAPINE (52)
CARBIDOPA\LEVODOPA (50)
VALPROATE (50)
OCRELIZUMAB (48)
Which NATALIZUMAB Alternatives Have Lower Cerebral atrophy Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK